-
While U.S. abortion rates are dropping, particularly among teens, the decline is not equally shared among all women. Rates have increased among those who are economically disadvantaged, according to just-published research from the New York City-based Alan Guttmacher Institute (AGI).
-
Will your facility soon be implementing the OraQuick Rapid HIV-1 Antibody Test? If so, there are several resources to help you get up to speed in offering this new service.
-
STD Quarterly: Register now for HIV prevention conference
-
You have just finished counseling a young woman who is frightened and confused after hearing she has contracted genital herpes. While you are able to offer her daily suppressive therapy to help reduce the frequency of outbreaks, you discuss the fact that there is no cure for this sexually transmitted disease (STD).
-
Editors note: This article discusses a use of quinacrine that has not been approved by the Food and Drug Administration.
-
Puzzled about protocols for dispensing emergency contraception (EC) to male partners? Wondering about the impact of depot medroxy-progesterone acetate (DMPA, Depo-Provera, Pharmacia Corp, Peapack, NJ) on lipid levels?
-
When women enter your family planning clinic, you have a wide array of contraceptive options to offer them. But when men ask about prevention methods, you have three choices: hand them condoms, advise abstinence, or counsel on vasectomy.
-
What if you could offer your patients a vaccine for protection against human papillomavirus (HPV), a sexually transmitted disease (STD) that can cause genital warts and cervical cancer? Just-published results from a randomized double-blind study indicates that an investigational vaccine developed by West Point, PA-based Merck & Co. reduced the incidence of human papillomavirus type 16 (HPV 16) infection in 100% of women who previously had not been infected with the STD.
-
Another study has shown an increase in mortality associated with the use of an oral IIb/IIIa receptor antagonist.
-
The 12-lead ECG and accompanying rhythm strip in the Figure were obtained from an asymptomatic and otherwise healthy 53-year-old man. What two things are unusual about the beat marked X? Did first degree AV block suddenly develop for the following sinus-conducted beat (beat Y)?